Munich - Delayed Quote • EUR ATAI Life Sciences NV (9VC.MU) Follow Add holdings 1.9300 -0.0430 (-2.18%) At close: June 13 at 8:00:48 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 9VC.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 9VC.MU View More All News Press Releases SEC Filings atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies atai Life Sciences to Participate in Upcoming Investor Conferences Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies Home Depot backs outlook as U.S. sales ticked up: Morning Buzz atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial Psychedelic: Exclusive talk with biotech company Clearmind Medicine Psychedelic: atai Life Sciences, NRx report quarterly results Atai Life Sciences Full Year 2024 Earnings: Misses Expectations